COVID19

Hut 8 Mining Production and Operations Update for September 2022

Retrieved on: 
Tuesday, October 4, 2022
Ethereum, VFX, Hacks, Internet, Hut, Classification, Company, HODL, Fraud, GPU, Nasdaq, Time, Technology, Risk, EDGAR, Industry, Hut 8, Medicine Hat, Machine learning, U.S. Securities and Exchange Commission, CEO, Semantic Web, Weather, System, Imagination, Graphics processing unit, Failure, Climate change, Proof of work, Goal, Growth, March 2015 North India unseasonal rain, Mining, Miner, Medicine, HPC, COVID19, ASIC, TSX, AI, Cryptocurrency, Uncertainty, Airline, Blockchain, Bitcoin

TORONTO, Oct. 4, 2022 /PRNewswire/ -- Hut 8 Mining Corp. (Nasdaq: HUT) (TSX: HUT), ("Hut 8" or the "Company") one of North America's largest, innovation-focused digital asset mining pioneers and high performance computing infrastructure provider, increased our Bitcoin holdings by 277 in the period ending September 30, bringing our total self-mined holdings to 8,388 Bitcoin.

Key Points: 
  • Hut 8 is one ofNorth America'slargest innovation-focused digital asset miners, led by a team of business-building technologists, bullish on bitcoin, blockchain, Web 3.0, and bridging the nascent and traditional high performance computing worlds.
  • Hut 8 was the first Canadian digital asset miner to list on the Nasdaq Global Select Market.
  • Thispress release includes "forward-looking information" and "forward-looking statements" within the meaning of Canadian securities laws andUnited Statessecurities laws, respectively (collectively, "forward-looking information").
  • These factors are not intended to represent a complete list of the factors that could affect Hut 8; however, these factors should be considered carefully.

Digihost Announces Y/Y 52% Increase in Quarterly Bitcoin Production and Provides Operations Update

Retrieved on: 
Tuesday, October 4, 2022
Bitcoin, Mining, No, News, TSX Venture Exchange, BTC, Goal, Growth, Policy, New York Public Service Commission, Program, Efficiency, COVID19, Alabama Power, Acquisition, Company, Renewable energy, Cryptocurrency

TORONTO, Oct. 04, 2022 (GLOBE NEWSWIRE) -- Digihost Technology Inc. (“Digihost” or the “Company”) (Nasdaq: DGHI; TSXV: DGHI), an innovative U.S. based Bitcoin (“BTC”) mining company, is pleased to provide unaudited comparative BTC production results for the month and quarter ended September 30, 2022, combined with an operations update. All monetary references are expressed in USD unless otherwise indicated.

Key Points: 
  • Digihost is currently moving forward expeditiously with other closing matters in order to complete the acquisition of the power plant in Q4 2022.
  • During Q3 2022, Digihost received Public Service Commission approval for an economic rider rate discount.
  • Through its self-mining operations and joint venture agreements, the Company is currently hashing at a rate of approximately 650 PH/s.
  • All hosting fees and joint venture profit sharing are treated as production costs in the Companys consolidated financial statements.

BiondVax announces financial plans to support its ongoing NanoAb pipeline development

Retrieved on: 
Friday, September 30, 2022
Income, UMG, Risk, COVID-19, Psoriatic arthritis, Psoriasis, SEC filing, Company, Compugen (Israeli company), Compliance, COVID19, Max Planck Society, Calendar, European Investment Bank, U.S. Securities and Exchange Commission, Letter, CEO, MPG, BiondVax, Annual report, RCA, BVXV, Coronavirus, Drug development, F-1, Form, ADSS, Security (finance), SEC, Animal, Asthma, Communication, Infection, Pharmaceutical industry, Nasdaq

As recently reported, in the coming weeks BiondVax intends to initiate a preclinical proof-of-concept study of the COVID-19 NanoAb as an inhaled therapy in COVID-19 infected animals.

Key Points: 
  • As recently reported, in the coming weeks BiondVax intends to initiate a preclinical proof-of-concept study of the COVID-19 NanoAb as an inhaled therapy in COVID-19 infected animals.
  • Assuming successful results, a first-in-human Phase 1/2a clinical trial of the COVID-19 NanoAb inhaled therapy will be initiated in 2023.
  • The research teams have also demonstrated strong neutralization by several NanoAb candidates of their respective target molecules.
  • With highly experienced pharmaceutical industry leadership,BiondVax is aiming to develop a pipeline of diversified and commercially viable products and platforms beginning with an innovative nanosized antibody (NanoAb) pipeline.

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Co-Diagnostics, Inc. of Class Action Lawsuit and Upcoming Deadline – CODX

Retrieved on: 
Tuesday, September 27, 2022
Securities Exchange Act of 1934, Laboratory, Time, Complaint, National Accreditation Board for Testing and Calibration Laboratories, COVID-19, Medicare, Liquid biopsy, Food, Calibration, Center, Clinical Laboratory Improvement Act, 1988, U.S. Securities and Exchange Commission, United, Company, Pomerantz, News, Lists of action films, COVID19, Person, LLP, Lists of schools in England, Electric Bond and Share Company v. Securities and Exchange Commission, Emergency Use Authorization, SEC Rule 10b-5, Defendant, Centers for Medicare & Medicaid Services, CLIA, Court, NASDAQ, Malaysian Qualifications Agency, RNA, Fuzzy Logix, DNA, District court, Ext, GLOBE, Food and Drug Administration, Infection, Pharmaceutical industry, Renewable energy

If you are a shareholder who purchased Co-Dx securities during the Class Period, you have until October 17, 2022 to ask the Court to appoint you as Lead Plaintiff for the class.

Key Points: 
  • If you are a shareholder who purchased Co-Dx securities during the Class Period, you have until October 17, 2022 to ask the Court to appoint you as Lead Plaintiff for the class.
  • To discuss this action, contact Robert S. Willoughby at [email protected] or 888.476.6529 (or 888.4-POMLAW), toll-free, Ext.
  • Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions.
  • The Firm has recovered numerous multimillion-dollar damages awards on behalf of class members.

Taoping Accelerates Growth in Large Smart Panel Market, Leveraging the Advantages of the Taoping Smart Cloud and Taoping Alliance Networks

Retrieved on: 
Tuesday, September 27, 2022
Cloud, Securities Exchange Act of 1934, Adoption, Acceleration, City, COVID-19, Securities Act of 1933, LCD, U.S. Securities and Exchange Commission, Company, Growth, Investment, COVID19, TAOP, Future TV Co. Ltd., IOT, Government, IDC, Intelligence, CEO, Yoy, Terminology, Solution, Cloud computing, Annual report, Bank of Communications, Leadership, NASDAQ, Research, SEC, Multimedia, AI, VR, View, Tax, Mobile phone, Television

Demand is being led by the adoption of new technologies ranging from 5G and AI, to cloud computing.

Key Points: 
  • Demand is being led by the adoption of new technologies ranging from 5G and AI, to cloud computing.
  • The digital transformation across industries is accelerating the application of smart scenario solutions and integration of IoT.
  • "We are taking full advantage of our Taoping alliance model, as we capture an increased number of smart large screen sales opportunities.
  • Relying on its self-developed smart cloud platform, TAOP also provides solutions and cloud services to industries such as smart community, new media and artificial intelligence.

The Prime Minister announces appointment of Ian Shugart as Privy Councillor

Retrieved on: 
Monday, September 26, 2022
Employment, Environment, Foreign Affairs, Climate change, Leadership, Privy council, COVID19, Clerk of the Privy Council (Canada), Employment and Social Development Canada, Constitution Act, Constitution Act, 1982, Cabinet, Person, Social change, Governor General of Canada, Animal

OTTAWA, ON, Sept. 26, 2022 /CNW/ - The Prime Minister, Justin Trudeau, today announced the appointment of Ian Shugart as Canada's newest Privy Councillor.

Key Points: 
  • OTTAWA, ON, Sept. 26, 2022 /CNW/ - The Prime Minister, Justin Trudeau, today announced the appointment of Ian Shugart as Canada's newest Privy Councillor.
  • An exceptional public service leader, Mr. Shugart is being honoured for his outstanding and dedicated service to Canadians.
  • From 2019 to 2022, Mr. Shugart was the 24th Clerk of the Privy Council and Secretary to the Cabinet.
  • Members are appointed by the Governor General, on the recommendation of the Prime Minister.

Purple Innovation Announces Formation of Special Committee to Evaluate Unsolicited Takeover Proposal from Coliseum Capital Management

Retrieved on: 
Monday, September 26, 2022
Board of directors, Special Committee on Decolonization, Adoption, Risk, Time, Shareholder rights plan, Sale, LLC, Rights, U.S. Securities and Exchange Commission, Purple (company), Company, COVID19, Forward-looking statement, Ownership, Sidley Austin, Plan, Annual report, Private Securities Litigation Reform Act, NASDAQ, Board, Committee, PRPL, SEC, Security (finance), Audit, Property management, Colosseum, LEHI, Purple

LEHI, Utah, Sept. 26, 2022 /PRNewswire/ -- Purple Innovation, Inc. (NASDAQ: PRPL) ("Purple" or the "Company"), a comfort innovation company known for creating the "World's First No Pressure® Mattress," today announced that its Board of Directors (the "Board"), in response to an unsolicited and non-binding proposal (the "Coliseum Proposal") from Coliseum Capital Management, LLC (together with certain of its funds and managed accounts, "Coliseum") on September 17, 2022 to acquire all of the outstanding capital stock of the Company it does not already own for $4.35 per share in cash, has formed a special committee of independent and disinterested directors (the "Special Committee") and the Special Committee has approved the adoption of a limited-duration shareholder rights plan (the "Rights Plan"). Coliseum beneficially owns approximately 45% of Purple's outstanding shares.

Key Points: 
  • The Board formed a Special Committee to take any and all actions necessary to evaluate the Coliseum Proposal and determine the course of action that is in the best interests of all of Purple's shareholders.
  • The Special Committee has not reached any conclusion as to the advisability or feasibility of a potential transaction at this time.
  • The Special Committee is comprised of independent directors Gary DiCamillo, Claudia Hollingsworth, Paul Zepf and Dawn Zier.
  • The Special Committee adopted the Rights Plan in response to the Coliseum Proposal, Coliseum's substantial increase in ownership of shares of Purple over the last year and the Special Committee's desire to have the time and flexibility necessary to evaluate the Coliseum Proposal.

Senstar Technologies Reports Second Quarter 2022 Financial Results

Retrieved on: 
Thursday, September 22, 2022
Income, Mission statement, Coronaviridae, GAAP, ID, EBITDA, Contract, Company, COVID19, SNT, Federal aid during the COVID-19 pandemic in Canada, U.S. Securities and Exchange Commission, Program, Travel, Solution, Annual report, EMEA, NASDAQ, Security (finance), Time in the United Kingdom, APAC, Time, Renewable energy, Video game, Bank

Revenue for the second quarter of 2022 was $9.1 million, a decrease of 9.7% compared with $10.1 million in the second quarter of 2021.

Key Points: 
  • Revenue for the second quarter of 2022 was $9.1 million, a decrease of 9.7% compared with $10.1 million in the second quarter of 2021.
  • Operating expenses for the second quarter of 2022 were $5.4 million, an increase of 11.2% compared to the prior year's second quarter operating expenses of $4.8 million.
  • Operating income was $0.1 million for the second quarter of 2022 compared to $2.2 million in the second quarter of 2021.
  • EBITDA from continuing operations for the second quarter was $0.5 million versus $2.5 million for the second quarter of 2021.

Global Urinary Incontinence (MedCore) Market Report 2022-2028 - ResearchAndMarkets.com

Retrieved on: 
Tuesday, September 20, 2022
Health, General Health, Data source name, Neuro, Competitive analysis, Ageing, Timeline of the COVID-19 pandemic, FDA, Disruptive innovation, TVT, Population, Russian Industrial Leaders Index, 13th Air Support Operations Squadron, COVID19, Urinary incontinence, Central, Female, Male, FDA recall policies, Central and Eastern Europe, Windows Internal Database, SIS, TOT, SWOT, Boston Scientific, Mergers and acquisitions, Incontinence, CAGR, Medical imaging, Baltic states

The "Urinary Incontinence Market Report with COVID Impact - Global - 2022 - 2028 - MedCore" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Urinary Incontinence Market Report with COVID Impact - Global - 2022 - 2028 - MedCore" report has been added to ResearchAndMarkets.com's offering.
  • The complete report suite on the global market for urinary incontinence device market includes urethral bulking agents (UBAs) and incontinence slings.
  • The urinary incontinence sling market is segmented into female and male urinary incontinence slings.
  • Global Urinary Incontinence Sling Market - Further segmented into:
    Female and male urinary incontinence slings.

Pomerantz Law Firm Announces the Filing of a Class Action Against Co-Diagnostics, Inc. and Certain Officers – CODX

Retrieved on: 
Monday, September 19, 2022
Securities Exchange Act of 1934, Laboratory, Time, Complaint, National Accreditation Board for Testing and Calibration Laboratories, COVID-19, Medicare, Liquid biopsy, Food, Calibration, Center, Clinical Laboratory Improvement Act, 1988, U.S. Securities and Exchange Commission, United, Company, Pomerantz, News, Lists of action films, COVID19, Person, LLP, Lists of schools in England, Electric Bond and Share Company v. Securities and Exchange Commission, Emergency Use Authorization, SEC Rule 10b-5, Defendant, Centers for Medicare & Medicaid Services, CLIA, Court, NASDAQ, Malaysian Qualifications Agency, RNA, Fuzzy Logix, DNA, District court, Ext, GLOBE, Food and Drug Administration, Infection, Pharmaceutical industry, Renewable energy

NEW YORK, Sept. 19, 2022 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Co-Diagnostics, Inc. (Co-Dx or the Company) (NASDAQ: CODX) and certain of its officers.

Key Points: 
  • NEW YORK, Sept. 19, 2022 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Co-Diagnostics, Inc. (Co-Dx or the Company) (NASDAQ: CODX) and certain of its officers.
  • If you are a shareholder who purchased Co-Dx securities during the Class Period, you have until October 17, 2022 to ask the Court to appoint you as Lead Plaintiff for the class.
  • Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions.
  • The Firm has recovered numerous multimillion-dollar damages awards on behalf of class members.